Growth Metrics

Merck (MRK) Dividends Paid - Common (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.31%
Dec 31, 2025 -0.64%
Sep 30, 2025 -2.21%
Jun 30, 2025 1.32%
Mar 31, 2025 5.07%
Dec 31, 2024 -0.10%
Sep 30, 2024 -1.66%
Jun 30, 2024 1.85%
Mar 31, 2024 5.29%
Dec 31, 2023 -0.16%
Sep 30, 2023 -1.59%
Jun 30, 2023 1.73%
Mar 31, 2023 5.89%
Dec 31, 2022 0.17%
Sep 30, 2022 -1.30%
Jun 30, 2022 1.43%
Mar 31, 2022 6.21%
Dec 31, 2021 -0.36%
Sep 30, 2021 -1.43%
Jun 30, 2021 1.70%
Mar 31, 2021 6.68%
Dec 31, 2020 -0.19%
Sep 30, 2020 -2.03%
Jun 30, 2020 1.68%
Mar 31, 2020 10.39%
Dec 31, 2019 0.79%
Sep 30, 2019 -5.04%
Jun 30, 2019 2.80%
Mar 31, 2019 11.82%
Dec 31, 2018 -0.62%
Sep 30, 2018 -1.98%
Jun 30, 2018 0.92%
Mar 31, 2018 1.25%
Dec 31, 2017 0.00%
Sep 30, 2017 -1.84%
Jun 30, 2017 1.00%
Mar 31, 2017 1.81%
Dec 31, 2016 -0.24%
Sep 30, 2016 -2.00%
Jun 30, 2016 1.64%
Mar 31, 2016 1.27%
Dec 31, 2015 -0.71%
Sep 30, 2015 -2.30%
Jun 30, 2015 1.72%
Mar 31, 2015 1.67%
Dec 31, 2014 -1.79%
Sep 30, 2014 -4.26%
Jun 30, 2014 3.80%
Mar 31, 2014 2.38%
Dec 31, 2013 0.08%
Sep 30, 2013 -5.48%
Jun 30, 2013 1.99%
Mar 31, 2013 135.15%
Dec 31, 2012 -390.99%
Sep 30, 2012 -0.23%
Jun 30, 2012 0.08%
Mar 31, 2012 137.55%
Dec 31, 2011 -389.87%
Sep 30, 2011 -0.09%
Jun 30, 2011 0.09%
Mar 31, 2011 134.16%
Dec 31, 2010 -391.28%
Sep 30, 2010 -0.67%
Jun 30, 2010 0.00%
Mar 31, 2010 47.85%
Dec 31, 2009 0.04%
Sep 30, 2009 0.06%
Jun 30, 2009 -0.01%